
Trending News Today: Epidiolex Meets Primary Goal in Trial for Tuberous Sclerosis Complex
Top news of the day from across the health care landscape.
GW Pharmaceuticals’ cannabidiol drug Epidiolex met the primary goal of treating seizures in patients with tuberous sclerosis complex (TSC) during a late-stage trial,
Some ingredients found in sunscreen may be absorbed into the bloodstream after just 1 day of use, according to an FDA study published in the
In an effort to reduce the spread of vaccine misinformation, Instagram said it is developing a “pop-up” that would appear on inaccurate vaccine-related content,
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.